Hunting for Serine 276-Phosphorylated p65 by Spooren, Anneleen et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 275892, 9 pages
doi:10.1155/2010/275892
Methodology Report
Hunting for Serine 276-Phosphorylated p65
Anneleen Spooren, Krzysztof Kolmus, Linda Vermeulen, Karlien Van Wesemael,
GuyHaegeman, and SarahGerlo
Laboratory of Eukaryotic Gene Expression (LEGEST), Department of Physiology, Ghent University, K.L. Ledeganckstraat 35,
9000 Ghent, Belgium
Correspondence should be addressed to Sarah Gerlo, sarah.gerlo@ugent.be
Received 13 August 2009; Revised 11 November 2009; Accepted 17 November 2009
Academic Editor: Susan A. Rotenberg
Copyright © 2010 Anneleen Spooren et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
The transcription factor nuclear factor kappaB (NF-κB) is one of the central mediators of inﬂammatory gene expression. Several
posttranslational modiﬁcations of NF-κB, regulating its transactivation ability, have been described. Especially phosphorylation of
the NF-κB subunit p65 has been investigated in depth and several commercial phosphospeciﬁc antibodies, targeting selected p65
residues, are available. One of the p65 residues, that is subject to phosphorylation by protein kinase A (PKA) as well as by mitogen-
stimulated kinase-1 (MSK-1), is the serine at position 276. Here, we have performed a detailed analysis of the performance of the
most commonly used commercial anti-P-p65 Ser276 antibodies. Our ﬁndings indicate that at least three widely used anti-P-p65
Ser276 antibodies do not detect p65 in vivo via Western Blot, but instead crossreact with PKA-regulated proteins. As PKA is one
of the main kinases responsible for phosphorylation of p65 at Ser276, this observation warrants cautious interpretation of data
generated using the tested antibodies.
1.Introduction
The transcription factor nuclear factor kappaB (NF-κB) was
originally identiﬁed as the factor driving immunoglobu-
lin transcription in B-cells [1]. Since then evidence has
accumulated, identifying NF-κB as the master regulator of
inﬂammatory gene expression in a variety of cell types [2, 3].
The NF-κB family of transcription factors consists of a group
of proteins (p50/p105, p52/p100, p65 (relA), c-Rel, and
RelB), all of which contain the N-terminal Rel-homology
domain (RHD), that is responsible for their DNA-binding
and homo- or heterodimerization ability. In addition, p65,
c-Rel and RelB also contain a transactivation domain (TAD).
The NF-κB proteins are kept in the cytoplasm through
physical interaction with inhibitors of the IκB (inhibitor
of κB) family. In response to proinﬂammatory cytokines
or pathogen-associated molecular patterns, the IκB kinase
(IKK), an upstream kinase complex, is activated. Activated
IKK phosphorylates the IκBm o l e c u l e s ,t a r g e t i n gt h e mf o r
ubiquitination-dependent degradation, and allowing the
migration of NF-κB dimers to the nucleus, where they can
activate gene transcription. More recent studies have shown
that,inmanyinstances,IκBdegradationandconsequentNF-
κBnucleartranslocationarenotsuﬃcientforfull-blownNF-
κB-dependent gene expression. A multitude of posttransla-
tional modiﬁcations of the NF-κB subunits, aﬀecting their
transactivation ability, has indeed been described [4–7].
The prototypical, most studied, NF-κB complex is the
p50-p65 dimer, and especially posttranslational modiﬁca-
tionsofthep65subunithavebeeninvestigatedingreatdetail.
The p65 residue contains several serine residues, which have
been shown to be subject to phosphorylation [5, 8]. One
of the p65 serine residues, which was originally shown to
be phosphorylated by the protein kinase A (PKA) upon
lipopolysaccharide (LPS) triggering, is the serine at position
276 [9]. Later it was discovered that the p65 serine 276
(Ser276) residue is also a target of the mitogen- and stress-
activated kinase-1 (MSK-1) after TNF-α stimulation [10].
Since its original demonstration in 1997, the role of phos-
phorylation of the p65 Ser276 residue has been intensively
studied, and the phosphorylation has been shown to be
involved in the expression of a variety of NF-κB-dependent
genes, in diﬀerent cell types and upon diﬀerent stimuli. Most
studies agree that Ser276 phosphorylation is required for the2 Journal of Biomedicine and Biotechnology
recruitment of the transcriptional coactivator CBP (CREB-
binding protein) and, hence, activates transcription of
particular p65 target genes [10, 11]. Very recently, a “knock-
in” mouse, expressing p65 with the Ser276 mutated to
alaninewasgenerated[12].Unfortunatelythesemiceshowed
a variegated phenotype, making it diﬃcult to interpret the
physiological function of p65 Ser276 phosphorylation.
Most of the reports investigating the function of p65
Ser276 phosphorylation have made use of a commercial
antibody (Cell Signaling no. 3037), directed against the
phosphorylated p65 Ser276 residue (for a complete list of
publications in which anti-phospho-p65 Ser276 antibodies
were used, we refer toSupplementary Table 1 in Supplemen-
tary Material available online at doi:10.1155/2009/275892).
This antibody was generated using a synthetic Keyhole
limpet hemocyanin (KLH)-coupled phosphopeptide, corre-
sponding to the amino acid residues surrounding Ser276 of
human NF-κB p65.
In this study, we have summarized our experimental data
obtained with the Cell Signaling no. 3037 and three other
commonly used anti-phospho(P)-p65 Ser276 antibodies.
Our ﬁndings suggest these antibodies are not suitable for
detection of Ser276-phosphorylated p65 in vivo by Western
Blotting and indicate that studies into the function of p65
Ser276 phosphorylation should be supported by additional,
antibody-independent assays.
2.MaterialsandMethods
2.1.Reagents. Isoproterenol(iso),forskolin,phorbol12-myr-
istate 13-acetate (PMA), chloro-phenyl-thio-cAMP (cAMP),
H89, and lipopolysaccharide (LPS) were purchased from
Sigma-Aldrich (St. Louis, MO). Recombinant human tumor
necrosis factor-α (TNF-α) was obtained from the Depart-
ment of Molecular Biology of Gent University (DMBR,
Gent, Belgium). siPKAcα (M-004649-01), sip65 (M-003533-
02), sip105/p50 (M-003520-01), and si-c-Rel (M-004768-
01) SMART pools and siControl (D-001210-05) were from
Dharmacon (Lafayette, CO).
2.2. Primary Antibodies. Four rabbit polyclonal antibodies
directed against the phosphorylated Ser276 residue of p65
were used in this study: anti-P-p65 Ser276 (no. 3037) from
CellSignaling (Danvers,MA),anti-P-p65 Ser276 (no. 11011)
from Signalway Antibody (SAB, Pearland, TX), anti-P-p65
Ser276 (no. 100-401-264) from Rockland (Gilbertsville, PA),
and a homemade anti-P-p65 Ser276 antibody (kind gift of
Prof. Dr. P. Cohen, University of Dundee, UK; produced
and puriﬁed by Drs. C. Armstrong and J. Leitch). Anti-p65
(C-20),anti-CBP,anti-p105/p50,anti-c-Rel,andanti-PKAcα
were from Santa Cruz (Santa Cruz, CA). Anti-tubulin was
from Sigma-Aldrich (St. Louis, MO).
2.3. Cell Culture. L929sA mouse ﬁbroblasts were described
previously [13]. Raw264.7 mouse macrophages, C2C12
mouse myoblasts, and L363 human multiple myeloma cells
were obtained from the European Collection of Cell Cultures
(Salisbury, UK). The human astrocytoma cell line 1321N1
was a kind gift from Prof. Dr. M¨ uller (University of Bonn,
Germany). NF-κB p65-deﬁcient, and wild type p65 (wt p65)
or p65 Serine to alanine mutated (p65 S/A) reconstituted,
mouse embryonic ﬁbroblasts (MEFs) were a gift from Dr.
Okazaki (Juntendo University, Japan). L363, Raw264.7, and
C2C12 cells were maintained in RPMI-1640 with Glutamax-
I, supplemented with 10% FCS, 100U/mL penicillin, and
100μg/mL streptomycin. All other cells were cultured in
DMEM with 10% FCS, 100U/mL penicillin and 100μg/mL
streptomycin. Cells were maintained at 37◦C in a humidiﬁed
5% CO2 atmosphere. Adherent cells were passaged using
0,05% (w/v) of trypsin in 0,4% (w/v) EDTA (all cell culture
reagents were from Invitrogen, Carlsbad, CA).
2.4. Western Blotting. T o t a lc e l l u l a re x t r a c t sw e r em a d ei n
S D Ss a m p l eb u ﬀer (62,5mM Tris-HCl pH 6.8, 2% SDS, 10%
glycerol, 0,5% β-mercapto-ethanol). Equal amounts of total
lysates from each condition were resolved by 8,5% SDS-
PAGE, transferred onto nitrocellulose membranes and anal-
ysed by Western Blotting. Chemiluminescent detection was
performed using horse-radish peroxidase (HRP)-coupled
secondary antibodies and Western lightning chemilumines-
cent reagent plus (Perkin Elmer LifeSciences, Boston, MA)
on the Kodak image station 440CF. For applications that
required higher sensitivity, Immobilion Nitrocellulose was
used, in combination with ﬂuorescent secondary antibodies
(Rockland, Gilbertsville, PA). Detection was performed on
the Odyssey Imaging System (Licor, Lincoln, NA). For
preadsorption of the antibodies in blocking experiments,
twice the volume of P-p65 Ser276 blocking peptide (Cell
Signaling, no. 1437) as volume of P-p65 Ser276 anti-
body was combined and incubated for 30 minutes at
4◦C, prior to adding the antibody/peptide mixture to the
blots.
2.5. siRNA Silencing of p65 and PKAcα. For siRNA exper-
iments cells were seeded in 6 wells (200000cells/well) and
transfected using the calcium phosphate method with 50nM
siGENOME SMART pools. siControl-transfected samples
were used to assess aspeciﬁc eﬀects. 48 hours after transfec-
tion and after overnight starvation, cellswere induced for the
indicated time periods. Subsequently, cells were lysed in SDS
sample buﬀer for Western Blotting analysis.
2.6. In Vitro Kinase Assay. Recombinant GST-p6512−317 and
the S276C-mutated version were produced and puriﬁed
according to the manufacturer’s instructions (Amersham
Pharmacia Biotech, Rainham, UK). 2μM of the protein
was incubated at 30◦C for 20min in kinase buﬀer (50mM
Tris pH 7.4, 10mM Mg(Ac)2, 0.1mM EGTA, and 0.1% β-
mercaptoethanol), supplemented with 0.1mM ATP and
15ng of recombinant active MSK-1 (Upstate, Billerica, MA).
250ng of recombinant proteins were subsequently spotted
on nitrocellulose membrane, or separated via SDS-PAGE,
and subjected to Western Blotting.Journal of Biomedicine and Biotechnology 3
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Figure 1: Anti-phospho-p65 Ser276 (Cell Signaling no. 3037) detects atypical (with MWs of 80 and 130kDa), inducible immunoreactivities in
diﬀerent cell types, induced with diﬀerent NF-κB-activating agents. Cells were stimulated for increasing times (L929sA, A549, L363) or for
30min (Raw264.7, C2C12, 1321N1) with TNF-α (2000 IU/mL), LPS (1μg/mL), PMA (10ng/mL), forskolin (forsk, 10μM) or isoproterenol
(iso,10μM).Forblockingexperiments,lysateswereloadedononegelinduplicateandaftertransfer,blotswerecutinhalf.Immunodetection
was performed in parallel, using Cell Signaling no. 3037 or Cell Signaling no. 3037 preincubated for at least 30 minutes with double volume
of blocking peptide (BLOCK). Arrow 1 indicates an immunoreactive band with an MW of 130kDa; arrow 2 indicates an immunoreactive
band of 80kDa.
3. Results
3.1.Anti-Phospho-p65Ser276(CellSignalingno.3037)Detects
aProminent130kDaBand,andaWeak80kDaBand,Induced
by Diﬀerent Stimuli (LPS, PMA, TNF, cAMP, Forskolin,
Isoproterenol) in Diﬀe r e n tC e l lT y p e s .B o t hB a n d sC a nB e
Blocked with the Phosphopeptide Used for Immunization. The
anti-phospho-p65 Ser276 (no. 3037), distributed by Cell
Signaling (Danvers, MA), was generated in rabbits using a
synthetic, KLH-coupled phosphopeptide, corresponding to
theresiduessurroundingSer276ofhumanp65.Accordingto
the accompanying data sheet, the antibody only detects p65
when it is phosphorylated at the Ser276 residue. Additional
information supplied by the datasheet is that, whereas it was
generated using a human peptide, the antibody crossreacts
with mouse and rat (and possibly dog) P-Ser276 p65.
Also according to the data sheet, Ser276-phosphorylated
p65 migrates at 80kDa, instead of the expected 65kDa, in
reducing gels. As shown in Figure 1,w ed e t e c t e ds e v e r a l
immunoreactive bands in lysates from diﬀerent human4 Journal of Biomedicine and Biotechnology
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Figure 2: The Cell Signaling no. 3037 anti-P-p65 Ser276-immunoreactive band persists in cells where p65 is silenced via an siRNA approach.
1321N1 cells were transiently transfected with control or p65 siRNA as described in Section 2. Cells were induced for 90min with TNF-α
(2000IU/mL), iso (10μM), or a combination of both stimuli. Presence of Ser276-phosphorylated p65 in cell lysates was analysed by Western
BlotusingCellSignalingno.3037(A1).130and80kDaimmunoreactivitiesareindicatedbyarrows.WesternBlottodetectanti-P-p65Ser536
(65kDa arrow) was performed on the same lysates (B1). Blots A1 and B1 were extensively washed and reprobed with anti-p65 to investigate
eﬃciency of p65 knock-down. Anti-p65 detected bands are marked with arrows (A2, B2). Finally, blots were reprobed with anti-tubulin to
check loading eﬃciency. Anti-tubulin-detected bands are marked with arrows (A3, B3).
(L363, 1321N1, A549) and mouse (L929sA, Raw264.7,
C2C12)celltypes.Phosphorylationofp65atSer276hasbeen
described after cAMP-independent activation of PKA by LPS
[9], as well as after cAMP-dependent stimulation of PKA
by the adenylyl cyclase activator forskolin [14]. In addition,
p65 was phosphorylated at Ser276 by MSK-1 upon TNF-α
treatment [10]. We indeed observed that signals activating
PKA (LPS, cAMP, isoproterenol and forskolin) or MSK-
1 (TNF, PMA) induced immunoreactive bands recognized
by the Cell Signaling no. 3037 antibody. In all investigated
cell types, the major immunoreactive band, induced by all
investigated stimuli, migrated with an apparent molecular
weight (MW) of 130kDa (arrow 1). In most cell types, a
minor 80kDa band (arrow 2), as expected based upon the
information supplied by the Cell Signaling datasheet, was
also induced. To investigate whether these immunoreactive
bands represent speciﬁc interactions with sequences homol-
ogous to that of the phosphopeptide used for immunization,
we performed blocking experiments in which the anti-P-
p65 Ser276 antibody was preadsorbed with this phospho-
peptide. As demonstrated in Figure 1, both the 80 and
130kDa induced immunoreactivities disappeared when the
blots were incubated with preadsorbed anti-P-p65 Ser276
antibody, indicating that the immunoreactivity is indeed the
result of a speciﬁc interaction with an amino acid sequence
homologous to that of the immunizing phosphopep-
tide.
3.2. The Cell Signaling no. 3037-Detected Bands Are Not Abro-
gated upon siRNA Mediated Knock-Down of p65. Because
we observed, unexpectedly, that cAMP-activating signals,
such as isoproterenol or forskolin, in addition to the 80kDa
band described in the Cell Signaling no. 3037 datasheet,
potently induced a 130kDa band that was recognized in a
speciﬁc manner by the Cell Signaling no. 3037 antibody in
diﬀerent cell types, we further investigated the authenticity
of this band using an siRNA approach in the 1321N1
human astrocytoma. As shown in Figure 2, whereas our
siRNA approach led to eﬃcient knock-down of p65 (A2,
B2), the 130kDa, isoproterenol-induced immunoreactivity
detected by Cell Signaling no. 3037, did not disappear or
even diminish (A1). Moreover, the 80kDa, presumable P-
Ser276 p65, band, induced by isoproterenol and, to a lesser
extent, TNF-α, also remained equally apparent in cells were
p65 expression was silenced (Figure 2,A 1 ) .A sac o n t r o l ,w e
also investigated whether p65 knock-down abrogated TNF-
α-induced phosphorylation of p65 at Serine 536. As evident
from Figure 2, the anti-P-p65 Ser536 antibody recognizes
a 65kDa immunoreactivity (B1) induced by TNF-α, that
comigrates with unphosphorylated p65 (Figure 2,B 2 )a n di sJournal of Biomedicine and Biotechnology 5
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Figure 3: Four independent anti-P-p65 Ser276 antibodies detect inducible bands, with MWs of 80 and 130kDa, that do not disappear upon
p65 knock-down, but are inhibited when PKAcα is silenced. 1321N1 cells were transiently transfected with control, p65 or PKAcα siRNA, as
described in Section 2. Cells were induced for 90 min with TNF-α (2000IU/mL), iso (10μM) or a combination of both stimuli. Presence
of Ser276-phosphorylated p65 in cell lysates was analysed by Western Blot using SAB no. 11011 (A1), Rockland no. 100-401-264 (B1), Cell
Signaling no. 3037 (B3), or a homemade anti-P-p65 Ser276 antibody (C1). 130 and 80 kDa immunoreactivities are indicated by arrows (1
and 2, resp.). Blots were extensively washed and reprobed with a mixture of anti-p65 and anti-PKAcα to investigate knock-down eﬃciency.
Anti-p65-detected bands are marked by the upper arrow, anti-PKAcα-reactive bands are marked by the lower arrow (A2, B2, C2). Tubulin
loading controls are added as Supplementary Figure 1.
indeed inhibited when p65 is silenced. Equal loading of the
gels was conﬁrmed by detection of tubulin (A3, B3).
3.3. Other Anti-Phospho-p65 Ser276 Antibodies Display the
Same Immunoreactivity as the Cell Signaling no. 3037
Antibody. The Bands Detected by All Presumable P-p65-
Ser276-Speciﬁc Antibodies Are Not p65, But Unrelated PKA-
Regulated Proteins. To investigate whether other available
antibodies would perhaps be more useful to detect Ser276
phosphorylated p65 via Western Blotting, we investigated
phosphorylation of p65 at Ser276 using two anti-P-p65
Ser276 antibodies distributed by independent companies
(no. 11011 from SAB and no. 100-401-264 from Rockland).
Inaddition,weusedahomemadeantibody(kindgiftofProf.
P. Cohen, University of Dundee, UK) that was previously
used to demonstrate Ser276 phosphorylation of p65 (10).
As apparent from Figure 3, like Cell Signaling no. 3037
(B3), both SAB no. 11011 (A1) and Rockland no. 100-
401-264 (B1) and the homemade antibody (C1) detect a
major 130kDa band (upper arrow), in isoproterenol-treated
cells. The SAB no. 11011 and homemade antibodies also
detect the 80kDa inducible band (lower arrow), whereas
this band was not apparent with the Rockland no. 100-401-
264 antibody. The SAB no. 11011 and homemade antibodies
in addition recognize several high molecular weight bands,6 Journal of Biomedicine and Biotechnology
someofwhichareinducedbyisoproterenol.WhereassiRNA-
mediated silencing clearly reduced the p65 content of the
cells (A2, B2, C2), none of the bands detected by the four
anti-P-p65 Ser276 antibodies was concomitantly reduced
(A1, B1, B3, C1).
The p65 Ser276 residue is part of a consensus recognition
site (RRXS) for PKA [15]. To investigate whether perhaps
the anti-P-p65 Ser276 antibodies crossreact with other PKA-
regulated proteins, we investigated what happens to the anti-
P-p65 Ser276-reactive bands upon silencing PKAcα.A se v i -
dent from Figure 3 (A1, B1, B3), the isoproterenol-induced
bands detected by all four anti-P-p65 Ser276 antibodies
were almost completely inhibited in cells where PKAcα was
(partially) silenced (A2, B2). Equal protein loading on the
gelswasconﬁrmedbydetectionoftheblotswithanti-tubulin
(Supplementary Figure 1) (the image in B3 was obtained
upon stripping of the B blot after tubulin detection and
reprobing with Cell Signaling no. 3037; knock-down and
tubulin controls are, hence, the same as for B1).
3.4. Cell Signaling no. 3037 and SAB no. 11011 Do Not Detect
Any Additional Immunoreactive Bands in p65 −/− MEF Cells,
Reconstituted with Wild Type p65, That Are Not Apparent in
p65 −/− MEF Cells. Whereas the siRNA-mediated knock-
down of p65 was very eﬃcient in the 1321N1 cells we used in
this study, knock-down is never 100% complete. Therefore,
we compared the immunoreactivity of the Cell Signaling
no. 3037 and SAB no. 11011 antibodies in Western Blots
from p65 knock-out MEF cells and MEF cells that had been
reconstituted with either wild type p65 (p65 wt) or p65
with Ser276 mutated to alanine (p65 S/A). As apparent from
Figure 4, the typical immunoreactive pattern (a prominent
130kDaandaweak80kDa)bandisalsopresentinMEFcells
that are deﬁcient of p65. Unlike in the other investigated cell
types, these bands seem to be present constitutively in MEF
cells.Inaddition a 50kDa bandis induced byforskolin. Most
importantly,notonesinglebandisdetectedbyeithertheCell
Signaling no. 3037 and SAB no. 11011 antibodies in p65 wt
reconstituted MEF cells, that is not already present in p65
knock-out cells (Figure 4, A1 and B1), which clearly have no
p65 (Figure 4,A 2a n dB 2 ) .
3.5. The Detected 80kDa and 130kDa Immunoreactivities
Are Not p105/p50 or c-Rel. In the datasheet of the Cell
Signaling no. 3037 antibody, it is mentioned that the anti-
body might crossreact with c-Rel and NF-κB1 (p105/p50)
when phosphorylated at the homologous Ser267 and Ser337
residues, respectively. As c-Rel and NF-κB1 p105 have
molecular weights of 70 and 105kDa, respectively, upon
phosphorylation they could theoretically appear as the 80
and 130kDa bands we observed on Western Blot. We
therefore investigated whether siRNA-mediated silencing of
p105/p50 or c-Rel aﬀected the appearance of these bands on
Western Blot. As apparent from Figure 5, whereas we were
abletoeﬃcientlyinhibittheexpressionofc-Relandp105,the
intensity of the 80 and 130kDa immunoreactive bands was
unaltered, indicating they do not represent phosphorylated
p105/p50 or c-Rel.
3.6. The Cell Signaling no. 3037 Antibody Recognizes p65
Ser276 Phosphorylation In Vitro. As the above described
results indicate that the Cell Signaling no. 3037 antibody (as
well as the other anti-P-p65 Ser276 antibodies we tested)
does not allow detection of in vivo Ser276 phosphorylation
of p65 via Western Blotting, we next assessed whether the
Cell Signaling no. 3037 antibody recognized in vitro Ser276-
phosphorylated p65. We therefore performed an in vitro
kinase assay, using recombinant MSK-1 to phosphorylate a
recombinant GST-p65 fusion protein. As demonstrated in
Figure 6, we could indeed detect phosphorylation of GST-
p65,thatwasblockedbypreadsorptionwiththeimmunizing
phosphopeptide (see dot blot), and that was inhibited by
inclusion of the PKA/MSK-1 inhibitor H89 in the kinase
reaction (see Western Blot). When a GST-p65 Ser276 to
cysteine mutant (SC) was used in the kinase reaction, no
immunoreactivity could be observed neither in the dot blot
nor in the Western Blot, underlining the speciﬁcity of the
recognition. These results indicate that, in vitro, the Cell
Signaling anti-P-p65 Ser276 antibody recognizes Ser276-
phosphorylated p65.
4. Discussion
Here we show that, several commonly used antibodies,
designed to detect Ser276-phosphorylated p65, react with
other PKA-regulated proteins, but do not detect Ser276-
phosphorylated p65 in vivo via Western Blotting.
According to the manufacturer’s data sheet, the Ser276-
phosphorylated p65 band detected by the Cell Signaling no.
3037 antibody migrates at 80kDa in denaturing gels. We
indeed detected a weak 80kDa band, that appears to be
coregulated with a much more prominent 130 kDa band, in
a variety of mouse and human cell types (L929sA, Raw264.7,
C2C12, MEF cells, L363, A549, and 1321N1 cells) and upon
treatment with diﬀerent known inducers (LPS, PMA, TNF,
forskolin, cAMP) of p65 Ser276 phosphorylation. In some
cell types, visualization of the 80kDa band required more
sensitive ﬂuorescent (Odyssey Imaging System, Licor, Lin-
coln, NA) development procedures than the standard HRP-
based chemiluminescent detection we are routinely using.
The 80 and 130kDa bands disappeared upon preadsorption
of the phosphospeciﬁc antibody with the phosphopeptide
that was used for immunization, indicating they represent
bands that are speciﬁcally recognized by the antibody.
We further investigated Ser276 phosphorylation of p65
mainly in the human 1321N1 astrocytoma cell line, upon
treatment with the β-adrenergic agonist isoproterenol (to
activatethePKApathway)andwithTNF-α(toactivateMSK-
1). In Western Blotting experiments, upon isoproterenol
treatment, the 1321N1 cells exhibit the typical immunoreac-
tive bands that are also detected by Cell Signaling no. 3037 in
other cell types and upon diﬀerent treatments: a very promi-
nent 130kDa band and a very weak 80kDa band, which
was also slightly induced by TNF-α. Our observation that
all immunoreactive bands persisted upon siRNA-mediated
silencing of p65 in 1321N1 cells, however, indicates that
these bands are not posttranslationally modiﬁed forms ofJournal of Biomedicine and Biotechnology 7
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Figure 4: Presence of anti-P-p65 Ser276-reactive bands in p65 deﬁcient MEF cells. p65 knock-out MEF cells (−/−), or p65 −/− MEF cells
reconstituted with wild type p65 (p65 wt) or p65 with Ser276 mutated to alanine (p65 S/A), were induced with forskolin (forsk, 10μM) for
0, 30, and 60min. Presence of Ser276-phosphorylated p65 in cell lysates was analysed by Western Blot using Cell Signaling no. 3037 (A1) or
SAB no. 11011 (B1). Blots were extensively washed and reprobed with anti-p65 to conﬁrm p65 absence in −/− MEFs, and p65 presence in
wt and S/A reconstituted MEFs (A2 and B2, arrows indicate anti-p65 detected bands).
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Figure 5: The detected 130 kDa and 80 kDa immunoreactivities are not NF-κB p105/p50 or c-Rel. 1321N1 cells were transiently transfected
with control, p105/p50 or c-Rel siRNA as described in Section 2. Cells were induced for 30min with TNF-α (2000IU/mL) or iso (10μM).
Presence of Ser276-phosphorylated p65 in cell lysates was analysed by Western Blot using Cell Signaling no. 3037 (A1, B1). 130 and 80kDa
immunoreactivities are indicated by arrows (1 and 2 resp.). Because of the overlap of the 130kDa and the p105 immunoreactive bands, blot
Awasﬁrststrippedandreprobedwithanti-p105/p50(A2).p105immunoreactivityisindicatedbytheupperarrow;p50immunoreactivityis
indicated by the lower arrow. Blot B was extensively washed and reprobed (without stripping) with anti-c-Rel (B2). c-Rel immunoreactivity
is indicated by an arrow. Tubulin was used as a loading control (A3, B3).8 Journal of Biomedicine and Biotechnology
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Figure 6:InvitrorecognitionofthephosphorylatedSerine276residue
of p65 by Cell Signaling no. 3037. Recombinant wt p65-GST or
SC mutant p65-GST fusion proteins were in vitro phosphorylated
using recombinant MSK-1. 250ng of the recombinant proteins
were spotted on a nitrocellulose membrane and subjected to
Western Blotting with Ser276 phospho-speciﬁc p65 antibody, either
preincubated with 10μg/mL phosphorylated peptide that was used
to generate the antibody (upper panel) or not. 1μg of recombinant
protein was separated by SDS-PAGE after the in vitro kinase assays
performed either in the presence of active MSK-1 and/or 10μM
H89 (lower panel) or not.
p65 (Figure 2). The successfulness of the siRNA approach
to knock-out p65 was corroborated by the ﬁnding that
silencing of p65 did inhibit TNF-α-induced p65 Ser536
phosphorylation(Figure 2).Inlinewiththeseﬁndings,using
Cell Signaling anti-P-p65 Ser276, we were unable to detect
the 130kDa and 80kDa immunoreactivities on Western Blot
upon successful immunoprecipitation of endogenous p65
in lysates from isoproterenol-treated 1321N1 cells, whereas
we did successfully recover Ser536-phoshorylated p65 (Sup-
plementary Figure 2). In addition, we were also unable to
detect any anti-P-p65 Ser276 immunoreactive bands when
Flag-taggedp65wastransientlytransfectedandsubsequently
concentrated by anti-Flag immunoprecipitation (Supple-
mentary Figure 3). We could however successfully detect
Ser276-phosphorylated p65 with the Cell Signaling anti-P-
p65 Ser276 using an in vitro kinase approach (Figure 6).
These observations indicate that the Cell Signaling anti-P-
p65Ser276antibodydoesspeciﬁcallyrecognizethephospho-
rylated p65 Ser276 residue when p65 is present abundantly,
and isolated from other possible crossreacting proteins, as
is the case in the in vitro assay. However, in an in vivo
situation, when p65 is present in a mixture of other proteins
with a homologous phosphorylation sequence, the antibody
clearly has a preference for other targets, that are either
more abundant, are more eﬃciently phosphorylated, or have
ah i g h e ra ﬃnity for the anti-P-p65 Ser276 antibodies than
Ser276-phosphorylatedp65.Aswehadidenticalresultsusing
diﬀerent lot numbers of Cell Signaling no. 3037, as well as
using anti-P-p65 Ser276 antibodies distributed by diﬀerent
companies (SAB no. 11011 and Rockland no. 100-401-264)
and a homemade antibody (Figure 3), we believe our results
are not artefactual. All investigated antibodies were probably
generated with very similar synthetic phosphopeptides (i.e.,
MQLRRPpSDRELSE for the homemade antibody and QLR-
RPpSDRELSE for the Rockland no. 100-401-264 antibody).
The sequence surrounding the p65 Ser276 residue resembles
aPKArecognitionsite[15]andourobservation,thatsiRNA-
mediated silencing of PKAcα leads to disappearance of the
anti-P-p65 Ser276-detected immunoreactivities (Figure 3),
indicates the antibodies indeed detect PKA-phosphorylated
proteins, but unfortunately not PKA-phosphorylated p65, in
1321N1 cells. The fact that we were unable to immunopre-
cipitate the inducible 80 or 130 kDa proteins using anti-P-
p65 Ser276 (data not shown), hampers identiﬁcation of the
crossreacting proteins via mass spectrometric analysis.
Although our data indicate that in the 1321N1 cell
line, the anti-P-p65 Ser276 antibodies we investigated do
not detect Ser276-phosphorylated p65, but rather crossreact
with other PKA-regulated proteins, we cannot claim, just by
analogy, that the bands, recognized by these antibodies in
other cell types, are neither Ser276-phosphorylated p65. We
did, however, obtain uncircumstantial evidence that at least
the Cell Signaling no. 3037 and SAB no. 11011 antibodies
lack speciﬁcity for p65, by the observation that in lysates
f r o mp 6 5 - d e ﬁ c i e n tM E Fc e l l s ,a n df r o mp 6 5M E Fc e l l s
reconstituted with wild type p65, the same immunoreactive
bands are detected (Figure 4). In addition, in MEF cells, as
in all other investigated cell types, constitutive immunore-
activities of 130kDa and 80kDa were apparent, indicating
these bands probably represent crossreacting proteins that
are abundantly present in most cell types.
Phosphorylation of p65 at the Ser276 residue has been
extensively investigated in other cell types than the ones we
have studied, yet several groups have demonstrated phos-
phorylation of p65 Ser276 via Western Blot in cells that we
alsoinvestigated (SupplementaryTable1),withoutreporting
any peculiarities on the MW of the bands shown in the
WesternBlots.Onlyinafewofthesepublications,additional,
antibody-independent, experiments were performed that
support the involvement of p65 Ser276 phosphorylation and
the conclusion of their studies.
The main conclusion from this study is that reports
on the function of Ser276 phosphorylation of p65 should
include additional, antibody-independent experiments.
This, however, narrows down p65 phosphorylation research
to the study of p65 −/− cells, reconstituted with selected
p65 point mutants. Very recently, the group that originally
reported Ser276 phosphorylation by PKA [9], and, as a
matter of fact, has never used the anti-P-p65-antibody
approach, has generated a transgenic knock-in mouse with
p65 Ser276 mutated to alanine [12]. Still, for those interested
in studying p65 phosphorylation in vivo in cells and tissues,
phosphospeciﬁcantibodiesareinvaluabletools.Wetherefore
believe it might be worthwhile to invest in the generationJournal of Biomedicine and Biotechnology 9
of a monoclonal anti-P-p65 Ser276 antibody, with a better
speciﬁcity and selectivity proﬁle than the currently available
polyclonal antibodies.
In summary, we believe the take-home-message from
our investigation is that caution is warranted in the inter-
pretation of data generated using the abovedescribed anti-
phospho-p65Ser276 antibodies.
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